Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Minoxidil and oral antioxidants helped improve hair growth in a patient with hair loss due to lupus.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Early intervention is important for limited systemic sclerosis patients due to higher pain and ulceration risks.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Semaglutide may help some skin disorders but can also cause skin issues.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib treatment is used for teenagers with alopecia areata.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Alitretinoin may cause irreversible hair curling as a side effect.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

The dog recovered fully after treatment, and tick prevention is advised to avoid reinfection.

Non-itchy rashes can indicate serious diseases like lupus.

Cetuximab can cause unusual hair growth and hair loss.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Tofacitinib may effectively treat folliculitis decalvans.

CTP-543 is generally safe for treating alopecia areata.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.